留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

氯沙坦对高血压性左心室肥厚跨室壁复极离散度及延迟整流钾电流的影响

纪荣静,  赵智晗,  臧小彪,  赵永辉

纪荣静, 赵智晗, 臧小彪, 赵永辉. 氯沙坦对高血压性左心室肥厚跨室壁复极离散度及延迟整流钾电流的影响[J]. 昆明医科大学学报.
引用本文: 纪荣静, 赵智晗, 臧小彪, 赵永辉. 氯沙坦对高血压性左心室肥厚跨室壁复极离散度及延迟整流钾电流的影响[J]. 昆明医科大学学报.
Rongjing JI, Zhihan ZHAO, Xiaobiao ZANG, Yonghui ZHAO. Effects of Losartan on Transwall Repolarization Dispersion and Delayed Potassium Rectification Currents in Hypertensive Left Ventricular Hypertrophy[J]. Journal of Kunming Medical University.
Citation: Rongjing JI, Zhihan ZHAO, Xiaobiao ZANG, Yonghui ZHAO. Effects of Losartan on Transwall Repolarization Dispersion and Delayed Potassium Rectification Currents in Hypertensive Left Ventricular Hypertrophy[J]. Journal of Kunming Medical University.

氯沙坦对高血压性左心室肥厚跨室壁复极离散度及延迟整流钾电流的影响

详细信息
  • 中图分类号: R541.3

Effects of Losartan on Transwall Repolarization Dispersion and Delayed Potassium Rectification Currents in Hypertensive Left Ventricular Hypertrophy

  • 摘要:   目的   探讨正常犬左心室心肌跨室壁复极异质性(transmural dispersion of repolarization,TDR)的电生理特征,并观察肾性高血压诱导的压力超负荷性左心室肥厚(left ventricular hypertrophy,LVH)对TDR及延迟整流钾电流的影响。  方法  15只成年比格犬随机分为正常组(Control)、LVH组和Losartan组,每组5只。成年比格犬采用“一肾一夹”法建立肾性高血压性LVH模型。超声心动图及HE、Masson染色评价模型建立情况。采用全细胞膜片钳技术记录左心室心内膜下层(Endo)、M层及心外膜下层(Epi)心肌细胞动作电位90%复极时程(action potential duration at 90% repolarization,APD90)及快速、缓慢延迟整流钾电流(IKr、IKs)密度。  结果  正常犬左心室心肌存在跨室壁复极异质性,M层心肌细胞APD90较Endo层及Epi层明显延长(P < 0.05)。与Control比较,LVH组M层及Epi层心肌细胞APD90进一步延长,其中M层延长最为显著(P < 0.01);同时M层心肌细胞IKr和IKs电流密度均明显降低(P < 0.05),提示压力超负荷性LVH进一步加重心肌复极异质性。Losartan干预后,M层APD90较LVH组明显缩短,IKr及IKs电流密度均有所恢复(P < 0.05),跨室壁复极离散度较LVH组减小。  结论  肾性高血压所致左心室肥厚可加重犬心肌跨室壁复极离散度,可能与M层心肌细胞IKr、IKs电流密度降低及复极延迟有关,氯沙坦可部分改善上述电生理异常。
  • 图  1  HE和Masson染色普通光学显微镜(×20)

    A:正常组左室心肌组织HE染色,B:Losartan组左室心肌组织HE染色,C:LVH组左室心肌组织HE染色; D:正常组左室心肌组织Masson染色,E:Losartan组左室心肌组织Masson染色,F:LVH组左室心肌组织Masson染色。

    Figure  1.  HE and Masson staining under a conventional light microscope (×20)

    图  2  正常组、LVH组、Losartan组犬三层心肌细胞之间IKs、Ikr的I-V曲线

    Figure  2.  I-V curves of IKs and Ikr among three layers of cardiomyocytes in the normal group,LVH group,and losartan-treated group in dogs

    图  3  正常组、LVH组、Losartan组犬同一层心肌细胞IKs、Ikr的I-V曲线

    Figure  3.  I-V curves of IKs and Ikr in cardiomyocytes from the same layer of the heart in the normal group,LVH group,and losartan group in dogs

    表  1  正常组、Losartan组和LVH组术后12周的血压值

    Table  1.   Blood pressure values at 12 weeks postoperatively in the normal group,the Losartan group,and the LVH group

    指标 n 正常组 Losartan组 LVH组 F P
    SBP(mmHg) 5 119.5 ± 16.92 125.7 ± 22.54 170.0 ±12.84**▲▲ 11.862 <0.001***
    DBP(mmHg) 5 76.99 ± 15.54 82.53 ± 19.82 119.5 ±16.92**▲▲ 8.702 0.005**
      注:LVH vs 正常组:*P < 0.05,**P < 0.01;LVH vs Losartan组:▲▲P < 0.01。
    下载: 导出CSV

    表  2  正常组、Losartan组和LVH组术前和术后12周超声心动图检测的指标

    Table  2.   Echocardiographic parameters in the normal group,the Losartan group,and the LVH group before surgery and at 12 weeks postoperatively

    指标n时间正常组Losartan组LVH组FP
    LVPWd(cm)5术前0.70 ± 0.060.70 ± 0.060.75 ± 0.120.5790.576
    5术后12周0.75 ± 0.120.78 ± 0.021.02 ± 0.06*▲17.853<0.001***
    LVPWs(cm)5术前1.45 ± 0.441.43 ± 0.421.16 ± 0.051.0560.378*
    5术后12周1.44 ± 0.411.45 ± 0.441.48 ± 0.19*0.0160.984
    IVSTd(cm)5术前0.69 ± 0.040.69 ± 0.050.69 ± 0.020.0001.000
    5术后12周0.69 ± 0.020.76 ± 0.020.83 ± 0.02**▲61.25<0.001***
    IVSTs(cm)5术前0.98 ± 0.130.99 ± 0.141.03 ± 0.060.2620.774
    5术后12周1.03 ± 0.061.08 ± 0.061.30 ± 0.14*▲11.5490.002**
    LVEDd(cm)5术前2.85 ± 0.232.85 ± 0.232.70 ± 0.090.9880.401
    5术后12周2.70 ± 0.093.39 ± 0.592.52 ± 0.366.5120.012*
    LVEDs(cm)5术前1.98 ± 0.232.04 ± 0.271.76 ± 0.321.4290.278
    5术后12周1.98 ± 0.202.00 ± 0.371.97 ± 0.310.0130.987
    FS5术前0.30 ± 0.130.29 ± 0.080.38 ± 0.071.2940.31
    5术后12周0.27 ± 0.070.40 ± 0.010.21 ± 0.02▲26.204<0.001***
      注:LVH组:术后vs术前:*P < 0.05,**P < 0.01;LVH术后vs Losartan组:▲P < 0.05。
    下载: 导出CSV

    表  3  左心室组织病理学定量分析

    Table  3.   Quantitative histopathological analysis of the left ventricle

    组别n心肌细胞横截面积(μm2)胶原容积分数CVF(%)血管周围纤维化面积(PVF,%)
    Control组5278.6 ± 19.42.84 ± 0.523.27 ± 0.68
    LVH组5463.8 ± 34.7**8.91 ± 1.07**10.84 ± 1.26**
    Losartan组5338.5 ± 26.3▲▲5.13 ± 0.79▲▲6.42 ± 0.93▲▲
    F—58.96169.1174.414
    P—<0.001***<0.001***<0.001***
      注:LVH组vs 正常组:**P < 0.01;LVH组vs Losartan组:▲▲P < 0.01。
    下载: 导出CSV

    表  4  三组犬左心室不同层心肌细胞动作电位复极90%时程(APD90)的比较

    Table  4.   Comparison of action potential duration at 90% repolarization (APD90) among different myocardial layers and groups

    组别nEndo(ms)M(ms)Epi(ms)FP
    正常组5257.20 ± 34.24310.20 ± 37.18*249.00 ± 44.48▲3.7330.055
    LVH组5287.50 ± 56.63518.90 ± 98.47**414.30 ± 118.60#7.3990.008
    Losartan组5223.20 ± 75.26276.80 ± 127.50237.00 ± 93.520.3550.709
    F—1.5459.4465.94——
    P—0.2530.003**0.016*——
      注:M层vs Endo层:**P < 0.01;M层 vs Epi层:▲P < 0.05;Endo层 vs Epi层:#P < 0.05。
    下载: 导出CSV

    表  5  三组犬左心室不同层心肌细胞Ikr、Iks电流密度比较

    Table  5.   Comparison of Ikr and Iks current densities in myocardial cells from different layers of the left ventricle in three canine groups

    指标组别nEndoMEpiFP
    Ikr正常组50.85 ± 0.641.23 ± 0.171.05 ± 0.151.1570.347
    Losartan组51.48 ± 0.191.15 ± 0.27*1.19 ± 0.332.160.158
    LVH组50.9233 ± 0.22820.8457 ± 0.36710.95 ± 0.150.2140.81
    F—3.5652.5991.421——
    P—0.0610.1150.279——
    Iks正常组53.59 ± 0.922.38 ± 0.40*3.76 ± 0.84▲▲4.9310.027
    Losartan组53.46 ± 1.232.15 ± 0.88*2.78 ± 0.902.0570.171
    LVH组52.90 ± 1.501.70 ± 0.70*3.09 ± 1.55▲1.6470.233
    F—0.431.2490.948——
    P—0.660.3220.415——
      注:M vs Endo层:*P < 0.05;M vs Epi层:▲P < 0.05,▲▲P < 0.01。
    下载: 导出CSV

    表  6  三组犬同一层心肌细胞之间的Ikr、Iks电流变化

    Table  6.   Changes in Ikr and Iks currents among cardiomyocytes of the same layer across the three canine groups

    指标心肌层n正常组LVH组Losartan组FP
    IkrEndo50.85 ± 0.640.92 ± 0.321.48 ± 0.19*#3.2410.075
    M51.23 ± 0.170.85 ± 0.37*1.15 ± 0.27▲2.5990.115
    Epi51.05 ± 0.150.97 ± 0.371.27 ± 0.281.4810.266
    F—1.1570.1522.216——
    P—0.3470.860.152——
    IksEndo53.59 ± 0.922.90 ± 1.503.46 ± 1.230.430.66
    M52.38 ± 0.401.70 ± 0.70*2.15 ± 0.89▲1.2490.322
    Epi53.76 ± 0.843.09 ± 1.562.97 ± 0.870.7010.515
    F—4.9311.6472.134——
    P—0.027*0.2330.161——
      注:LVH vs 正常组:*P < 0.05;LVH vs Losartan组:▲P < 0.05;Losartan vs 正常组:#P < 0.05。
    下载: 导出CSV
  • [1] Alexander P M A, Nugent A W, Daubeney P E F, et al. Long-term outcomes of hypertrophic cardiomyopathy diagnosed during childhood: Results from a National Population-Based Study[J]. Circulation, 2018, 138(1):
    [2] Norrish G, Field E, McLeod K, et al. Clinical presentation and survival of childhood hypertrophic cardiomyopathy: A retrospective study in United Kingdom[J]. Eur Heart J, 2019, 40(12): 986-993. doi: 10.1093/eurheartj/ehy798
    [3] Teekakirikul P, Padera R F, Seidman J G, et al. Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics[J]. J Cell Biol, 2012, 199(3): 417-421. doi: 10.1083/jcb.201207033
    [4] Park H, Kim H K, Jeong M H, et al. Clinical impacts of inhibition of renin–angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention[J]. J Cardiol, 2017, 69(1): 216-221. doi: 10.1016/j.jjcc.2016.03.012
    [5] Faria-Costa G, Leite-Moreira A, Henriques-Coelho T. Cardiovascular effects of the angiotensin type 2 receptor[J]. Rev Portuguesa De Cardiol Engl Ed, 2014, 33(7-8): 439-449. doi: 10.1016/j.repc.2014.02.011
    [6] Antzelevitch C, Di Diego J M. Tpeak-Tend interval as a marker of arrhythmic risk[J]. Heart Rhythm, 2019, 16(6): 954-955. doi: 10.1016/j.hrthm.2019.01.017
    [7] Tashiro N, Muneuchi J, Ezaki H, et al. Ventricular repolarization dispersion is a potential risk for the development of life-threatening arrhythmia in children with hypertrophic cardiomyopathy[J]. Pediatr Cardiol, 2022, 43(7): 1455-1461. doi: 10.1007/s00246-022-02867-3
    [8] Lei M, Salvage SC, Jackson AP, et al. Cardiac arrhythmogenesis: roles of ion channels and their functional modification[J]. Frontiers in Physiology, 2024, 15: 1342761. doi: 10.3389/fphys.2024.1342761
    [9] Maron B J. Clinical course and management of hypertrophic cardiomyopathy[J]. N Engl J Med, 2018, 379(7): 655-668. doi: 10.1056/NEJMra1710575
    [10] Maron B J, Doerer J J, Haas T S, et al. Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980-2006[J]. Circulation, 2009, 119(8): 1085-1092. doi: 10.1161/CIRCULATIONAHA.108.804617
    [11] Marian A J, Braunwald E. Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy[J]. Circ Res, 2017, 121(7): 749-770. doi: 10.1161/CIRCRESAHA.117.311059
    [12] Sayer G, Bhat G. The renin-angiotensin-aldosterone system and heart failure[J]. Cardiol Clin, 2014, 32(1): 21-32, vii. doi: 10.1016/j.ccl.2013.09.002
    [13] Shimizu M, Ino H, Okeie K, et al. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion[J]. Clin Cardiol, 2002, 25(7): 335-339. doi: 10.1002/clc.4950250706
    [14] 李峰, 冯耀光. 大鼠心肌肥厚模型概述[J]. 中国现代医生, 2010, 48(32): 6-7, 11. doi: 10.3969/j.issn.1673-9701.2010.32.004
    [15] 田作军, 陈长兵, 廖海星, 等. 肾血管性高血压犬中血管紧张素Ⅱ的肾内作用机制探讨[J]. 广东医学, 2013, 34(2): 191-193. doi: 10.3969/j.issn.1001-9448.2013.02.010
    [16] 孙琪, 黄荣桂, 郑兴中, 等. 一肾一夹肾血管性高血压动物模型的制作[J]. 临床军医杂志, 2007, 35(6): 812-814. doi: 10.3969/j.issn.1671-3826.2007.06.002
    [17] 田作军, 陈长兵, 廖海星, 等. 肾血管性高血压犬中血管紧张素Ⅱ的肾内作用机制探讨[J]. 广东医学, 2013, 34(2): 191-193.
    [18] Liu D W, Antzelevitch C. Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. A weaker IKs contributes to the longer action potential of the M cell[J]. Circ Res, 1995, 76(3): 351-365. doi: 10.1161/01.RES.76.3.351
    [19] Flaim S N, Giles W R, McCulloch A D. Contributions of sustained INa and IKv43 to transmural heterogeneity of early repolarization and arrhythmogenesis in canine left ventricular myocytes[J]. Am J Physiol Heart Circ Physiol, 2006, 291(6): H2617-H2629. doi: 10.1152/ajpheart.00350.2006
    [20] Viswanathan P C, Shaw R M, Rudy Y. Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: A simulation study[J]. Circulation, 1999, 99(18): 2466-2474. doi: 10.1161/01.CIR.99.18.2466
    [21] Sutherland F J, Shattock M J, Baker K E, et al. Mouse isolated perfused heart: Characteristics and cautions[J]. Clin Exp Pharma Physio, 2003, 30(11): 867-878. doi: 10.1046/j.1440-1681.2003.03925.x
    [22] 李泱, 马杰, 肖建民, 等. 兔左室壁三层心肌细胞的分离及动作电位、钙和钾电流分布的异质性[J]. 生理学报, 2002, 54(5): 369-374. doi: 10.3321/j.issn:0371-0874.2002.05.003
    [23] Yan G X, Rials S J, Wu Y, et al. Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization[J]. Am J Physiol Heart Circ Physiol, 2001, 281(5): H1968-H1975. doi: 10.1152/ajpheart.2001.281.5.H1968
    [24] Khokhlova A, Iribe G, Katsnelson L, et al. The effects of load on transmural differences in contraction of isolated mouse ventricular cardiomyocytes[J]. J Mol Cell Cardiol, 2018, 114: 276-287. doi: 10.1016/j.yjmcc.2017.12.001
    [25] White E, Le Guennec J Y, Nigretto J M, et al. The effects of increasing cell length on auxotonic contractions; membrane potential and intracellular calcium transients in single Guinea-pig ventricular myocytes[J]. Exp Physiol, 1993, 78(1): 65-78.
    [26] Saint D A, Kelly D, MacKenzie L. The contribution of MEF to electrical heterogeneity and arrhythmogenesis[M]//Mechanosensitivity of the Heart. Dordrecht: Springer Netherlands, 2010: 275-300.
    [27] Zeng T, Bett G C, Sachs F. Stretch-activated whole cell currents in adult rat cardiac myocytes[J]. Am J Physiol Heart Circ Physiol, 2000, 278(2): H548-H557. doi: 10.1152/ajpheart.2000.278.2.H548
    [28] Stones R, Calaghan S C, Billeter R, et al. Transmural variations in gene expression of stretch-modulated proteins in the rat left ventricle[J]. Pflügers Arch Eur J Physiol, 2007, 454(4): 545-549. doi: 10.1007/s00424-007-0237-z
  • [1] 李佳娴, 杜娟, 林希悦, 宝福凯, 李贞, 刘德华.  异质性万古霉素中介金黄色葡萄球菌耐药机制研究进展, 昆明医科大学学报. 2026, 47(9): 19-32. doi: 10.12259/j.issn.2095-610X.S20260902
    [2] 刘文祥, 曹宇, 邵瑞飞, 罗丽, 侯庆琦, 蒋立虹.  主动脉瘤及夹层节段异质性中血管平滑肌细胞表型转换的调控机制和诊断治疗研究进展, 昆明医科大学学报. 2026, 47(8): 1-12. doi: 10.12259/j.issn.2095-610X.S20260801
    [3] 杜高波, 贾小凤, 余强, 李晓鹃.  原发性高血压患者血清miR-192表达水平与左室肥厚的关系, 昆明医科大学学报. 2023, 44(2): 139-143. doi: 10.12259/j.issn.2095-610X.S20230204
    [4] 龙佑玲, 潘登, 熊田珍, 潘月, 苏勇, 熊霖, 吴彦, 栗莹.  心电向量图诊断高血压病左心室异常的临床应用, 昆明医科大学学报. 2021, 42(4): 113-116. doi: 10.12259/j.issn.2095-610X.S20210421
    [5] 陶四明, 陈韵羽, 魏榕, 韩明华.  去肾动脉交感神经对高血压大鼠急性期肾素活性及心室重塑的影响, 昆明医科大学学报. 2021, 42(2): 96-102. doi: 10.12259/j.issn.2095-610X.S20210218
    [6] 白向锋, 陶杰, 蒙俊, 杨伟.  左心室重建术对左心室重构的影响, 昆明医科大学学报. 2017, 38(11): 34-39.
    [7] 原斌.  缺血性心肌病经皮冠状动脉介入治疗对改善左心室功能、降低心血管事件发生率的作用, 昆明医科大学学报. 2016, 37(06): -.
    [8] 张瑜.  血流向量成像定量评价正常成人左心室涡流特征, 昆明医科大学学报. 2015, 36(10): -.
    [9] 龙琼华.  2型糖尿病对老年高血压患者颈动脉内膜中层厚度与左心室质量指数的影响及相关性, 昆明医科大学学报. 2015, 36(10): -.
    [10] 杜映荣.  血管紧张素原(AGT)基因M235T多态性与中老年高血压并抑郁症的相关性研究, 昆明医科大学学报. 2014, 35(02): -.
    [11] 黄红.  老年高血压患者血压季节变化与血管紧张素II相关性研究, 昆明医科大学学报. 2014, 35(11): -1.
    [12] 白向锋.  脑钠素(BNP)评价左心室重建术对急性心肌梗死后左心室重构的影响, 昆明医科大学学报. 2014, 35(10): -1.
    [13] 郭玥.  先心病心脏重构患者血清血管紧张素转化酶2水平研究, 昆明医科大学学报. 2013, 34(02): -.
    [14] 罗庆祎.  单心动周期全容积成像评价心肌梗死患者左心室收缩功能收缩同步性, 昆明医科大学学报. 2013, 34(06): -.
    [15] 陈丽星.  血管紧张素-(1-7)对野百合碱诱导的肺动脉高压及右心室重构的影响, 昆明医科大学学报. 2013, 34(01): -.
    [16] 龙莉.  血管紧张素原基因M235T多态性在云南彝族人群中的分布, 昆明医科大学学报. 2012, 33(11): 1-1.
    [17] 杨榆玲.  血管紧张素II 1型受体A1166C多态性在云南彝族人群中的分布, 昆明医科大学学报. 2012, 33(05): -.
    [18] .  犬颅脑创伤后局部脑代谢的微透析监测, 昆明医科大学学报. 2011, 32(09): -.
    [19] .  正常犬脊髓MR弥散成像的初步研究, 昆明医科大学学报. 2011, 32(05): -.
    [20] 李雄.  氧自由基在血管紧张素Ⅱ诱导ECV304细胞增殖中的作用, 昆明医科大学学报. 2007, 28(06): -.
  • 加载中
图(3) / 表(6)
计量
  • 文章访问数:  5
  • HTML全文浏览量:  5
  • PDF下载量:  0
  • 被引次数: 0
出版历程

目录

    /

    返回文章
    返回